Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 September 2008, Vol. 112, No. 5, pp. 1740-1749.
Prepublished online as a Blood First Edition Paper on May 12, 2008; DOI 10.1182/blood-2007-08-106302.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Tables, and Figures
Right arrow All Versions of this Article:
blood-2007-08-106302v1
112/5/1740    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Ny, A.
Right arrow Articles by Dewerchin, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ny, A.
Right arrow Articles by Dewerchin, M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 10, 2007
Accepted March 6, 2008

Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles

Annelii Ny, Marta Koch, Wouter Vandevelde, Martin Schneider, Christian Fischer, Antonio Diez-Juan, Elke Neven, Ilse Geudens, Sunit Maity, Lieve Moons, Stephane Plaisance, Diether Lambrechts, Peter Carmeliet, and Mieke Dewerchin*

Department of Transgene Technology and Gene Therapy, VIB, K.U.Leuven, Leuven, Belgium
The Center for Transgene Technology and Gene Therapy (CTG), K.U.Leuven, Leuven, Belgium

* Corresponding author; email: mieke.dewerchin{at}med.kuleuven.be.

The importance of the lymphangiogenic factor VEGF-D and its receptor VEGFR-3 in early lymphatic development remains largely unresolved. We therefore investigated their role in Xenopus laevis tadpoles, a small animal model allowing chemicogenetic dissection of developmental lymphangiogenesis. Single morpholino antisense oligo knockdown of VEGF-D did not affect lymphatic commitment, but transiently impaired lymphatic endothelial cell (LEC) migration. Notably, combined knockdown of VEGF-D with VEGF-C at suboptimal morpholino concentrations, resulted in more severe migration defects and lymphedema formation than the corresponding single knockdowns. Knockdown of VEGFR-3 or treatment with the VEGFR-3 inhibitor MAZ51 similarly impaired lymph vessel formation and function and caused pronounced edema. VEGFR-3 silencing by morpholino knockdown, MAZ51 treatment, or VEGF-C/D double knockdown also resulted in dilation and dysfunction of the lymph heart. These findings document a critical role of VEGFR-3 in embryonic lymphatic development and function, and reveal a previously unrecognized modifier role of VEGF-D in the regulation of embryonic lymphangiogenesis in frog embryos.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

VEGF-D: a modifier of embryonic lymphangiogenesis
Terhi Karpanen and Kari Alitalo
Blood 2008 112: 1547-1548. [Full Text] [PDF]





 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020